Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Lewis

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
The Pediatric Infectious Disease Journal|August 17, 2002
Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohortSteven B Black, Edwin Lewis, Henry R Shinefield, et al.
Human Vaccines|September 22, 2010
Vaccine effectiveness against laboratory-confirmed influenza in infants: A matched case control studyLauren W Cochran, Steven Black, Nicola P Klein, et al.
The Pediatric Infectious Disease Journal|June 15, 2004
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser PermanenteSteven Black, Henry Shinefield, Roger Baxter, et al.
ACS Omega|July 20, 2018
Stability of the Na<sup>+</sup> Form of the Human Telomeric G-Quadruplex: Role of Adenines in Stabilizing G-Quadruplex StructureBrenna A Tucker, Jason S Hudson, Lei Ding, et al.
Pharmacoepidemiology and Drug Safety|January 3, 2018
Bias from outcome misclassification in immunization schedule safety researchSophia R Newcomer, Martin Kulldorff, Stan Xu, et al.
Vaccine|June 3, 2009
An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety DatalinkW Katherine Yih, James D Nordin, Martin Kulldorff, et al.
Vaccine|July 15, 2019
Long-term effectiveness of zoster vaccine live for postherpetic neuralgia preventionNicola P Klein, Joan Bartlett, Bruce Fireman, et al.
The Pediatric Infectious Disease Journal|August 31, 2006
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographsJohn Hansen, Steven Black, Henry Shinefield, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccineSteven B Black, Carolyn O Cimino, John Hansen, et al.
BMJ (Clinical Research Ed.)|November 8, 2023
Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health recordsNicola P Klein, Joan Bartlett, Bruce Fireman, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
The Pediatric Infectious Disease Journal|August 17, 2002
Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohortSteven B Black, Edwin Lewis, Henry R Shinefield, et al.
Human Vaccines|September 22, 2010
Vaccine effectiveness against laboratory-confirmed influenza in infants: A matched case control studyLauren W Cochran, Steven Black, Nicola P Klein, et al.
The Pediatric Infectious Disease Journal|June 15, 2004
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser PermanenteSteven Black, Henry Shinefield, Roger Baxter, et al.
ACS Omega|July 20, 2018
Stability of the Na<sup>+</sup> Form of the Human Telomeric G-Quadruplex: Role of Adenines in Stabilizing G-Quadruplex StructureBrenna A Tucker, Jason S Hudson, Lei Ding, et al.
Pharmacoepidemiology and Drug Safety|January 3, 2018
Bias from outcome misclassification in immunization schedule safety researchSophia R Newcomer, Martin Kulldorff, Stan Xu, et al.
Vaccine|June 3, 2009
An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety DatalinkW Katherine Yih, James D Nordin, Martin Kulldorff, et al.
Vaccine|July 15, 2019
Long-term effectiveness of zoster vaccine live for postherpetic neuralgia preventionNicola P Klein, Joan Bartlett, Bruce Fireman, et al.
The Pediatric Infectious Disease Journal|August 31, 2006
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographsJohn Hansen, Steven Black, Henry Shinefield, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccineSteven B Black, Carolyn O Cimino, John Hansen, et al.
BMJ (Clinical Research Ed.)|November 8, 2023
Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health recordsNicola P Klein, Joan Bartlett, Bruce Fireman, et al.
Pageof 7